Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
FP08 - Multimodality Management of Advanced Lung Cancer
- Type: Posters (Featured)
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP08.04 - Tumour Spread Through Air Space (STAS) In Lung Metastases
00:00 - 00:00 | Presenter: Alberto Sandri
- Abstract
Loading...
-
+
P14 - Immunotherapy (Phase II/III Trials) - Clinical Trial in Progress
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 7
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P14.03 - Vibostolimab Plus Pembrolizumab With/Without Docetaxel vs Docetaxel in NSCLC After Platinum Chemotherapy and Immunotherapy
00:00 - 00:00 | Presenter: Solange Peters
- Abstract
Loading...
-
+
P42 - Multimodality of Advanced Lung Cancer - Prognostic Factors
- Type: Posters
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P42.01 - Tumor Size is an Independent Prognostic Factor after Pulmonary Metastasectomy
00:00 - 00:00 | Presenter: Simona Sobrero
- Abstract
Loading...
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 18
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P45.12 - Renal Function Change During Alectinib in ALK Rearranged Non-Small Cell Lung Cancer: A Retrospective Multicentre Analysis
00:00 - 00:00 | Author(s): Daniele Pignataro
- Abstract
Loading...
-
+
P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 32
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P59.20 - Natural History of KRAS Mutant Non-Small-Cell Lung Cancer in the Immunotherapy Era: A Single-Centre Retrospective Study
00:00 - 00:00 | Presenter: Paolo Bironzo
- Abstract
Loading...
-
+
IS08 - Industry Symposium Sponsored by Eli Lilly And Company: Personalizing and Optimizing Treatment for Metastatic NSCLC Patients with EGFR Mutations - Is There More We Can Do?
- Type: Industry Supported Symposium
- Track: N.A.
- Presentations: 6
- Coordinates: 9/10/2021, 05:45 - 06:45, Industry Symposium Auditorium via Industry Hub
-
+
IS08.02 - Is a One Size Fits All Approach Still Appropriate for NSCLC with an EGFR Mutation, Are All Mutations Equal?
05:50 - 06:05 | Presenter: Silvia Novello
- Abstract
No abstract available for this presentation
-
+
MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future
- Type: Mini Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Presentations: 8
- Coordinates: 9/12/2021, 20:00 - 21:00, Program Auditorium
-
+
MA12.07 - Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center
20:40 - 20:45 | Presenter: Maristella Bungaro
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic
- Type: Oral
- Track: Nursing and Allied Health Professionals
- Presentations: 6
- Moderators:Sara McLaughlin-Barrett
- Coordinates: 9/12/2021, 20:00 - 21:00, Program Auditorium
-
+
OA17.04 - The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers
20:30 - 20:40 | Author(s): Matthew Smeltzer
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL05 - Plenary 5: Closing Plenary: Immunotherapy and Beyond: Future Directions (Japanese, Mandarin, Spanish Translation Available)
- Type: Plenary
- Track: N.A.
- Presentations: 6
- Moderators:Silvia Novello
- Coordinates: 9/14/2021, 21:15 - 22:15, Program Auditorium
-
+
PL05.01 - CAR T-cell Therapy for Thoracic Cancers
21:15 - 21:27 | Presenter: Prasad Adusumilli
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL05.02 - Determinants of Immunotherapy Resistance in Lung Cancer
21:27 - 21:39 | Presenter: Kurt Schalper
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL05.03 - Radiation/IO Synergy/Evolving Technology
21:39 - 21:51 | Presenter: Ken Harada
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL05.04 - IO in the Surgical Resectable Patient
21:51 - 22:03 | Presenter: Jamie Chaft
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL05.05 - Live Discussion with Speakers
22:03 - 22:13
- Abstract
No abstract available for this presentation
-
+
PL05.06 - Closing Remarks
22:13 - 22:15
- Abstract
No abstract available for this presentation
